New drug combo tested for tough-to-treat cancers
NCT ID NCT05423262
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 27 times
Summary
This study tests an experimental drug called TRK-950, alone or with another drug (nivolumab), in people with advanced solid tumors or melanoma that have not responded to standard treatments. The goal is to check safety, find the right dose, and see if the drug can shrink tumors. About 49 adults will take part across three parts of the study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Keio University Hospital
RECRUITINGShinjuku-Ku, Tokyo, 160-8582, Japan
Contact
-
Kumamoto University Hospital
RECRUITINGKumamoto, Kumamoto, 860-8556, Japan
Contact
-
Nagoya City University Hospital
RECRUITINGNagoya, Aichi-ken, 467-8602, Japan
Contact
-
National Cancer Center Hospital
RECRUITINGChuo Ku, Tokyo, 104-0045, Japan
Contact
-
National Hospital Organization Kyushu Cancer Center
RECRUITINGFukuoka, Fukuoka, 811-1395, Japan
Contact
-
Niigata Cancer Center Hospital
RECRUITINGNiigata, Niigata, 951-8566, Japan
Contact
-
Saitama Medical University International Medical Center
RECRUITINGHidaka, Saitama, 350-1298, Japan
Contact
-
Sapporo Medical University Hospital
RECRUITINGSapporo, Hokkaido, 060-8543, Japan
Contact
-
Shinshu University Hospital
RECRUITINGMatsumoto, Nagano, 390-8621, Japan
Contact
-
Shizuoka Cancer Center
RECRUITINGNagaizumi-chō, Shizuoka, 411-8777, Japan
Contact
Conditions
Explore the condition pages connected to this study.